-
Healthy Habits
Power OffToo much time spent looking at electronic devices can come at a cost.
by Cameron Walker
-
Q&A
Hope Amid the HypeHematologist-oncologist David Scadden traces the history, promise and uncertainties of treatment advances in Cancerland: A Medical Memoir.
by Marci A. Landsmann
-
From the Editor-in-Chief
Why Are Liver Cancer Death Rates Up?Hepatitis C infection, obesity and alcohol can contribute to more cases of liver cancer.
by William G. Nelson, MD, PhD
-
Forward Look
Some Prostate Cancer Patients Face a Difficult DecisionSurgery and radiation have similar benefits but different side effects.
by Stephen Ornes
-
Forward Look
Looking for Brain MetastasesStudies aim to identify when screening is beneficial.
by Sue Rochman
-
Forward Look
Lynch Syndrome Linked to More CancersStudy findings suggest patient screening has been too narrow.
by Sharon Tregaskis
-
Forward Look
What’s Next? Spring 2019Reducing chemotherapy side effects with a ‘drug sponge.'
by Bradley Jones
-
Policy Matters
Eliminating HPV-Related CancerHPV vaccination and screening can help eradicate cervical cancer and other malignancies.
by Anna R. Giuliano, PhD
-
Keeping an Eye on CancerImaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.
by Charlotte Huff
-
First Immunotherapy Approved for Breast CancerMedical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
